Faster access than browser!Similarities between Clomipramine and Major depressive disorder
Clomipramine and Major depressive disorder have 20 things in common (in Unionpedia): Alpha-2 adrenergic receptor, Amitriptyline, Antipsychotic, Developing country, Dopamine receptor D1, Duloxetine, Epileptic seizure, Fluoxetine, Hypomania, Mania, Moclobemide, Monoamine oxidase inhibitor, Neuroleptic malignant syndrome, Selective serotonin reuptake inhibitor, Serotonin, Serotonin–norepinephrine reuptake inhibitor, Suicide, Treatment-resistant depression, Tricyclic antidepressant, Venlafaxine.
Alpha-2 adrenergic receptor
The alpha-2 (α2) adrenergic receptor (or adrenoceptor) is a G protein-coupled receptor (GPCR) associated with the Gi heterotrimeric G-protein.
Alpha-2 adrenergic receptor and Clomipramine · Alpha-2 adrenergic receptor and Major depressive disorder ·
Amitriptyline
Amitriptyline, sold under the brand name Elavil among others, is a medicine primarily used to treat a number of mental illnesses.
Amitriptyline and Clomipramine · Amitriptyline and Major depressive disorder ·
Antipsychotic
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
Antipsychotic and Clomipramine · Antipsychotic and Major depressive disorder ·
Developing country
A developing country (or a low and middle income country (LMIC), less developed country, less economically developed country (LEDC), underdeveloped country) is a country with a less developed industrial base and a low Human Development Index (HDI) relative to other countries.
Clomipramine and Developing country · Developing country and Major depressive disorder ·
Dopamine receptor D1
Dopamine receptor D1, also known as DRD1, is a protein that in humans is encoded by the DRD1 gene.
Clomipramine and Dopamine receptor D1 · Dopamine receptor D1 and Major depressive disorder ·
Duloxetine
Duloxetine, sold under the brand name Cymbalta among others, is a medication mostly used for major depressive disorder, generalized anxiety disorder, fibromyalgia and neuropathic pain.
Clomipramine and Duloxetine · Duloxetine and Major depressive disorder ·
Epileptic seizure
An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain.
Clomipramine and Epileptic seizure · Epileptic seizure and Major depressive disorder ·
Fluoxetine
Fluoxetine, also known by trade names Prozac and Sarafem, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class.
Clomipramine and Fluoxetine · Fluoxetine and Major depressive disorder ·
Hypomania
Hypomania (literally "under mania" or "less than mania") is a mood state characterized by persistent disinhibition and elevation (euphoria).
Clomipramine and Hypomania · Hypomania and Major depressive disorder ·
Mania
Mania, also known as manic syndrome, is a state of abnormally elevated arousal, affect, and energy level, or "a state of heightened overall activation with enhanced affective expression together with lability of affect." Although mania is often conceived as a "mirror image" to depression, the heightened mood can be either euphoric or irritable; indeed, as the mania intensifies, irritability can be more pronounced and result in violence, or anxiety.
Clomipramine and Mania · Major depressive disorder and Mania ·
Moclobemide
Moclobemide (sold as Amira, Aurorix, Clobemix, Depnil and Manerix) is a reversible inhibitor of monoamine oxidase A (RIMA) drug primarily used to treat depression and social anxiety. It is not approved for use in the United States, but is approved in other Western countries such as the UK and Australia (TGA approved in December 2000). It is produced by affiliates of the Hoffmann–La Roche pharmaceutical company. Initially, Aurorix was also marketed by Roche in South Africa, but was withdrawn after its patent rights expired and Cipla Medpro's Depnil and Pharma Dynamic's Clorix became available at half the cost. No significant rise in blood pressure occurs when moclobemide is combined with amines such as tyramine-containing foods or pressor amine drugs, unlike with the older nonselective and irreversible monoamine oxidase inhibitors (MAOIs), which cause a severe rise in blood pressure with such combination. Due to the lack of anticholinergic, cardiovascular, cognitive and psychomotor impairments moclobemide is advantageous in the elderly as well as those with cardiovascular disease.
Clomipramine and Moclobemide · Major depressive disorder and Moclobemide ·
Monoamine oxidase inhibitor
Monoamine oxidase inhibitors (MAOIs) are a class of drugs that inhibit the activity of one or both monoamine oxidase enzymes: monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B).
Clomipramine and Monoamine oxidase inhibitor · Major depressive disorder and Monoamine oxidase inhibitor ·
Neuroleptic malignant syndrome
Neuroleptic malignant syndrome (NMS) is a life-threatening reaction that occasionally occurs in response to neuroleptic or antipsychotic medication.
Clomipramine and Neuroleptic malignant syndrome · Major depressive disorder and Neuroleptic malignant syndrome ·
Selective serotonin reuptake inhibitor
Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that are typically used as antidepressants in the treatment of major depressive disorder and anxiety disorders.
Clomipramine and Selective serotonin reuptake inhibitor · Major depressive disorder and Selective serotonin reuptake inhibitor ·
Serotonin
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.
Clomipramine and Serotonin · Major depressive disorder and Serotonin ·
Serotonin–norepinephrine reuptake inhibitor
Serotonin–norepinephrine reuptake inhibitors (SNRIs) are a class of antidepressant drugs that treat major depressive disorder (MDD) and can also treat anxiety disorders, obsessive-compulsive disorder (OCD), attention-deficit hyperactivity disorder (ADHD), chronic neuropathic pain, fibromyalgia syndrome (FMS), and menopausal symptoms.
Clomipramine and Serotonin–norepinephrine reuptake inhibitor · Major depressive disorder and Serotonin–norepinephrine reuptake inhibitor ·
Suicide
Suicide is the act of intentionally causing one's own death.
Clomipramine and Suicide · Major depressive disorder and Suicide ·
Treatment-resistant depression
Treatment-resistant depression (TRD) or treatment-refractory depression is a term used in clinical psychiatry to describe cases of major depressive disorder (MDD) that do not respond adequately to appropriate courses of at least two antidepressants.
Clomipramine and Treatment-resistant depression · Major depressive disorder and Treatment-resistant depression ·
Tricyclic antidepressant
Tricyclic antidepressants (TCAs) are a class of medications that are used primarily as antidepressants.
Clomipramine and Tricyclic antidepressant · Major depressive disorder and Tricyclic antidepressant ·
Venlafaxine
Venlafaxine, sold under the brand name Effexor among others, is an antidepressant of the selective serotonin-norepinephrine reuptake inhibitor (SNRI) class.
Clomipramine and Venlafaxine · Major depressive disorder and Venlafaxine ·
The list above answers the following questions
- What Clomipramine and Major depressive disorder have in common
- What are the similarities between Clomipramine and Major depressive disorder
Clomipramine and Major depressive disorder Comparison
Clomipramine has 243 relations, while Major depressive disorder has 278. As they have in common 20, the Jaccard index is 3.84% = 20 / (243 + 278).
References
This article shows the relationship between Clomipramine and Major depressive disorder. To access each article from which the information was extracted, please visit:
